Skip to content

Other product segments

Jornay PM
$635M0.0%
Symproic
$70M0.0%
Symproic and other
$70M0.0%

Similar metrics at other companies

Blue Bird Corporation logo
BLBDBus — Cost of goods sold
$267.83M-2.6%
Fresh Del Monte Produce logo
FDPBanana — Cost of products sold
$340.6M-1.8%
Micron Technology logo
MUCMBU — Cost of goods sold
$2B+52.0%
Oil-Dri Corporation of America logo
ODCBusiness to Business Products — Cost of Product and Service Sold
$26.69M+6.2%
Enerpac Tool Group logo
EPACProducts — Cost of products sold
$56.91M+6.9%
Micron Technology logo
MUCDBU — Cost of goods sold
$1.46B+51.1%

Other financials

Income statement

See full
Revenue$193.5M+8.9%
Gross profit$117.2M+20.5%
Operating income$30.9M+42.5%
Net income$14.5M+500%
EPS (diluted)$0.40+471%

Balance sheet

See full
Cash & equivalents$289.6M+147%
Total debt$5.2M-19.5%
Total equity$312.4M+33.3%
Total assets$1.7B+1.3%

Cash flow

See full
Operating cash flow$57.1M+3.1%
CapEx$270.0K-66.2%
Free cash flow$56.8M+4.1%

Valuation

See full
Market cap$1.13B+17.9%
Enterprise value$845.67M-0.3%
P/E15.1×-6.8×
P/S1.4×0.0×

Profitability

See full
Gross margin60.7%+3.0pp
Operating margin23.7%+2.3pp
Net margin9.4%+2.8pp
FCF margin41.4%+10.4pp

Returns & leverage

See full
Return on equity27.4%+8.2pp
Debt / equity0.0×
Current ratio1.7×+0.6×

Where this comes from

Reported directly by Collegium Pharmaceutical, Inc. in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsGross.

The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Collegium Pharmaceutical, Inc.'s belbuca — cost.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Collegium Pharmaceutical, Inc.'s belbuca — cost?
Collegium Pharmaceutical, Inc. (COLL) reported belbuca — cost of $360M in Q1 2026.
How has Collegium Pharmaceutical, Inc.'s belbuca — cost changed year-over-year?
Collegium Pharmaceutical, Inc.'s belbuca — cost decreased by 0.0% year-over-year, from $360M to $360M.
What is the long-term trend for Collegium Pharmaceutical, Inc.'s belbuca — cost?
Over 3 years (2022 to 2025), Collegium Pharmaceutical, Inc.'s belbuca — cost has grown at a -0.2% compound annual growth rate (CAGR), from $1.45B to $1.44B.
What does belbuca — cost mean?
Reflects the total direct costs associated with the production, distribution, and support of the Belbuca product line. Monitoring this helps evaluate the direct cost structure and gross margin efficiency of the specific product segment.